Bibliographic record
Abstract
The CSIL Report The world market for safety syringes provides a comprehensive market intelligence on the global level of safety syringes. The findings of the Report focus on safety syringes, but during the analysis other types of syringes have been considered. The research aims at better understanding the global market for safety syringes, its international competitive landscape, and the new opportunities arising from the evolution of its regulation frameworks and the COVID-19 outbreaks. GEOGRAPHICAL COVERAGE: Europe (European Union + UK); USA; Canada; Asia-Pacific (Australia, China, Hong Kong, India, Indonesia, South Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, and Thailand); Middle East (Iran, Iraq, Israel, Kuwait, Saudi Arabia, Syria, and United Arab Emirates); South Americ (Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, and Venezuela); Others (Rest of the world). LEGISLATIVE FRAMEWORK: The Report lists the main injection safety legislations signed by governments and international organizations, which are leading the transition from traditional to safety-engineered syringes in health care settings in order to reduce needle stick injuries. MARKET OVERVIEW AND FORECASTS: Syringes imports and exports are broken down by country and by geographical area of destination/origin (the time frame considered is 2009-2019); The global consumption of syringes is reported in volume and value and it is broken down by geographical area, by application and product (the time frame considered is: 2010-2019), in this section is estimated the size of the market for medical and surgical syringes for human applications and the market for safety syringes (value and volume, 2019); The forecasted evolution of the demand for medical and surgical syringes as well as for safety syringes is provided in volume for the years 2018-2025. COMPETITIVE SYSTEM: An analysis of the leading players selling safety syringes is provided. Sales data, market shares and short profiles of the leading players in the safety syringes industry are also available. An APPENDIX on the Covid-19 vaccine pre-purchases across the globe and total number of COVID-19 vaccinations administered in 2020 is also included.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.003 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.002 | 0.004 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.007 | 0.005 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.050 | 0.010 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".